Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease With 11C-ER176
NCT04840979Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- May 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]ER176 in Alzheimer's disease (AD), sponsored by Columbia University. Started May 2021; status: active, not recruiting.
02
Drugs
[11C]ER176
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04840979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840979.